Skip to content
Benjamin Cassiday

All work

Chapter 05 of 06 · 2023–Now

Supermind

Currently Chief Information Officer and Chief Product Officer

The situation

Supermind prepared a digital and commercial platform for the market expected to follow approval of MDMA-assisted therapy for PTSD. In August 2024 the FDA declined to approve Lykos Therapeutics’ application for the therapy.

What I do

I’m responsible for product and information systems. I helped launch the Psychedelics Uncensored newsletter in January 2024.

I also envisioned and built Psybrary after seeing a need for access to harm-reduction information. It answers psychedelic research questions with sources, at ask.psychedelics.com. How I built it is on the AI page.

When that market did not open, I helped turn the work toward longevity.

The marketMDMA-assisted therapy, after approvallongevity. In August 2024 the FDA declined to approve Lykos Therapeutics’ application, and I helped turn the work toward longevity.